Focus On the Impact of Chronic Constipation: A Managed Care Perspective
Including proceedings from a symposium held in Boston, Massachusetts
Activity Date: February 2007  — Activity Info: Volume 4, (2)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

James C. Eoff III, PharmD
Executive Associate Dean
Professor of Clinical Pharmacy
University of Tennessee College of Pharmacy
Memphis, Tennessee
Dr Eoff reports having no financial relationships with corporate organizations related to this activity.


Anthony J. Lembo, MD
Assistant Professor of Medicine
Division of Gastroenterology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts
Dr Lembo reports serving as a consultant for Novartis, Sucampo Pharmaceuticals

Notice: In accordance with ACPE Criteria for Quality, the audience is advised that the articles in this CE activity contain no reference(s) to unlabeled or unapproved uses of drugs or devices.

University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.ticals, Inc, and Takeda Pharmaceuticals North America, Inc.
Home | Contact Us | View Account | Need Help?